CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG

Clinical trials for CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG trials appear

Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Major trial tests new drug combo for Tough-to-Treat lung cancer

Disease control Completed

This large, completed Phase 3 trial tested whether adding a drug called olaparib to a standard immunotherapy and chemotherapy regimen could better control advanced squamous non-small cell lung cancer. It involved 851 people with newly diagnosed, advanced disease that had spread. …

Matched conditions: CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG

Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG

Get alerted when new CARCINOMA, SQUAMOUS CELL, NON-SMALL-CELL LUNG trials appear

Major trial tests new drug combo for Tough-to-Treat lung cancer